Category: Analyst’s Comments

Analyst's Comments

Adverum Biotechnologies, Inc. (ADVM) stock is rising, here is the reason why?

Adverum Biotechnologies, Inc. (ADVM) experiences an incline of 18.35% in the aftermarket. However, the last trading session closed at $2.18 with an increase of 0.46%. 2-Year OPTIC Data Demonstrating Sustained Durability On 1st October 2021, ADVM announced new long-term results from the OPTIC clinical trial

Analyst's Comments

Why EyeGate Pharmaceuticals, Inc. (EYEG) stock is gloomy day?

Shares of EyeGate Pharmaceuticals, Inc. (EYEG) stock were declining in the intraday session today on October 1, 2021. EYEG stock price saw a downtrend of 7.21% to drop at $2.09 a share at the time of this writing. The stock was green in the previous